Acurx pharmaceuticals to discuss second quarter 2023 financial results and provide business update

Staten island, n.y. , july 24, 2023 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the company will discuss its second quarter 2023 financial results on monday, august 14, 2023, at 8:00 am et before the u.s. financial markets open.
ACXP Ratings Summary
ACXP Quant Ranking